The assessment by the blood pressure self-monitoring of the residual efficacy of telmisartan compared to perindopril;Évaluation de l'efficacité résiduelle du telmisartan par automesure tensionnelle comparée au perindopril

Archives des Maladies du Coeur et des Vaisseaux

Volumn 95, Issue 7-8, 2002, Pages 738-742

  Ragot, S ^a   Meunier, A ^b   Poterre, M ^b   Bourkaib R ^c   Herpin, D ^d  

^a Department of Biostatistics   (France)

^b GLAXOSMITHKLINE   (France)

^c POITIERS UNIVERSITY HOSPITAL   (France)

^d NONE

Author keywords

[No Author keywords available]

Indexed keywords

PERINDOPRIL; TELMISARTAN; BENZIMIDAZOLE DERIVATIVE; BENZOIC ACID DERIVATIVE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;

ADULT; AGED; ANALYSIS OF VARIANCE; ARTICLE; BLOOD PRESSURE MONITORING; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; FEMALE; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; RANDOMIZED CONTROLLED TRIAL; SIDE EFFECT; STATISTICAL ANALYSIS; BLOOD PRESSURE; DRUG EFFECT; MIDDLE AGED; PROSPECTIVE STUDY;

ADULT; AGED; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; BENZIMIDAZOLES; BENZOATES; BLOOD PRESSURE; BLOOD PRESSURE MONITORING, AMBULATORY; FEMALE; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; PERINDOPRIL; PROSPECTIVE STUDIES;

EID: 0036657176     PISSN: 00039683     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (10)

1. Mengden T, Battig B, Vetter W. Self-measurement of blood pressure improves the accuracy and reduces the number of subjects in clinical trials. J Hypertens Suppl 1991; 9: S336-7.
2. Mengden T, Binswanger B, Spuhler T, Weisser B, Vetter W. The use of self-measured blood pressure determinations in assessing dynamics of drug compliance in a study with amladipine once a day, morning versus evening. J Hypertens 1993; 11: 1403-11.
3. Chatellier G, Day M, Bobrie G, Menard J. Feasibility study of N-of-1 trials wit blood pressure self-monitoring in hypertension. Hypertension 1995; 25: 294-301.
4. Bobrie G, Dutrey-Dupagne C, Vaur L et al. Demonstration of differences in the effect of 2 antihypertensive agents by self blood pressure measurement: comparison of trandolapril and perindopril]. Therapie 1997; 52: 187-93.
5. Mallion JM, Siché JP, Lacourcière Y. ABPM comparison of the antihypertensive profiles of the selective angiotensin II receptor antagonists telmisartan and losartan in patients with mild-to-moderate hypertension. J Hum Hypertens. 1999; 13: 657-64.
6. Ragot S, Genes N, Vaur L, Herpin D. Comparison of three blood pressure measurement methods for the evaluation of two antihypertensive drugs: feasibility, agreement, and reproducibility of blood pressure response. Am J Hypertens 2000; 13: 632-9.
7. Black HR, Graff A, Shute D et al. Valsartan, a new angiotensin II antagonist for the treatment of essential hypertension: efficacy, tolerability and safety compared to an angiotensin-converting enzyme inhibitor, lisinopril. J Hum Hypertens 1997; 11: 483-9.
8. Tikkanen I, Omvik P, Jensen HA. Comparison of the angiotensin II antagonist losartan with the angiotensin converting enzyme inhibitor enalopril in patients with essential hypertension. J Hypertens 1995; 13: 1343-51.
9. Dickerson JE, Hingarani AD, Ashby MJ, Palmer CR, Brown MJ. Optimisation of antihypertensive treatment by crossover rotation of four major classes. Lancet 1999; 353: 2008-13.
10. Ohkubo T, Imai Y, Tsuji I et al. Home blood pressure measurement has a stronger predictive power for mortality than does screening blood pressure measurement: a population-based observation in Ohosama, Japan. J Hypertens 1998; 16: 971-5.